XDS MasterLab - FOSS NIRSystems, Inc
Content Uniformity Made Easy The FOSS MasterLab is based on XDS Near-Infrared (NIR) technology and provides pharmaceutical manufacturers with a rapid, reliable and non-destructive test method covering the full array of solid dosage forms: layered, coated or cored tablets, capsules, caplets, geltabs and gelcaps. The versatile sampling mechanism of the MasterLab offers an automated and unattended reflectance or transmission analysis of a tray of multiple tablets or vials. Visit FOSS NIRSystems Learn more about the XDS MasterLab Contact Us
Content Uniformity Made Easy
The FOSS MasterLab is based on XDS Near-Infrared (NIR) technology and provides pharmaceutical manufacturers with a rapid, reliable and non-destructive test method covering the full array of solid dosage forms: layered, coated or cored tablets, capsules, caplets, geltabs and gelcaps.
The versatile sampling mechanism of the MasterLab offers an automated and unattended reflectance or transmission analysis of a tray of multiple tablets or vials.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
